Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Daré Bioscience, Inc. DARE
$1.01
+$0 (0.01%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
87546283.00000000
-
week52high
1.47
-
week52low
0.82
-
Revenue
-9990000000
-
P/E TTM
0
-
Beta
1.20899600
-
EPS
-0.36000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:30
Описание компании
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 01 апр 2022 г. |
| Roth Capital | Buy | Buy | 30 июн 2021 г. |
| HC Wainwright & Co. | Buy | 18 дек 2020 г. | |
| Brookline Capital | Buy | 28 апр 2020 г. | |
| Maxim Group | Buy | 17 авг 2018 г. | |
| HC Wainwright & Co. | Buy | Buy | 13 дек 2022 г. |
| JonesTrading | Buy | 01 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fair John A | A | 290000 | 290000 | 24 янв 2023 г. |
| Walters-Hoffert Lisa | A | 290000 | 290000 | 24 янв 2023 г. |
| JOHNSON SABRINA MARTUCCI | A | 750000 | 750000 | 24 янв 2023 г. |
| RASTETTER WILLIAM H | A | 38000 | 38000 | 23 июн 2022 г. |
| Steele Robin Joan | A | 38000 | 38000 | 23 июн 2022 г. |
| Ononye-Onyia Sophia Nnenna | A | 38000 | 38000 | 23 июн 2022 г. |
| Matz Gregory W | A | 38000 | 38000 | 23 июн 2022 г. |
| Grossman Jessica D. | A | 38000 | 38000 | 23 июн 2022 г. |
| Blanchard Cheryl R | A | 38000 | 38000 | 23 июн 2022 г. |
| Kelley Susan L. | A | 38000 | 38000 | 23 июн 2022 г. |
Новостная лента
Daré Bioscience, Inc. (DARE) Q1 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 22:10
Daré Bioscience, Inc. (NASDAQ:DARE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Sabrina Martucci Johnson – President and Chief Executive Officer John Fair – Chief Commercial Officer Lisa Walters-Hoffert – Chief Financial Officer Conference Call Participants Catherine Novack – Jones Research Kumar Raja – ROTH Capital Kemp Dolliver – Brookline Capital Markets Doug Tsao – H.C. Wainwright Operator Welcome to the conference call hosted by Daré Bioscience to review the Company's Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.
Daré Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023
GlobeNewsWire
04 мая 2023 г. в 08:00
SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 11, 2023, to review its financial results for the quarter ended March 31, 2023 and to provide a Company update.
Dare Bioscience, Inc. (DARE) Q4 2022 Earnings Call Transcript
Seeking Alpha
30 мар 2023 г. в 23:16
Dare Bioscience, Inc. (NASDAQ:DARE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Sabrina Johnson - President & Chief Executive Officer Lisa Walters-Hoffert - Chief Financial Officer John Fair - Chief Strategy Officer Conference Call Participants Catherine Novack - Jones Research Douglas Tsao - H.C. Wainwright Kumaraguru Raja - ROTH Capital Joanne Lee - Maxim Group Kemp Dolliver - Brookline Capital Markets Operator Welcome to the conference call hosted by Daré Bioscience to review the company's Financial Results for the Year Ended December 31, 2022 and to provide a general business update.
Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023
GlobeNewsWire
23 мар 2023 г. в 08:00
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 30, 2023, to review its financial results for the year ended December 31, 2022 and to provide a Company update.
Daré Bioscience to Present at the 35th Annual Roth Conference
GlobeNewsWire
01 мар 2023 г. в 08:00
SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, the company's President and CEO, will present at the 35th Annual Roth Conference, being held March 12-14, 2023 in Laguna Niguel, CA.